Neuroscience, Science, Research, Brain.
were randomly assigned to receive an IV infusion of either esketamine or a placebo shortly after birth. They were then interviewed 18–30 hours after birth, and again at 7 and 42 days. By 42 days after birth, 6.7% of the participants given esketamine had experienced a major depressive episode